As of Dec 05
| +0.47 / +0.59%|
The 12 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 84.00, with a high estimate of 85.00 and a low estimate of 80.00. The median estimate represents a +5.67% increase from the last price of 79.49.
The current consensus among 19 polled investment analysts is to Hold stock in St. Jude Medical. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.